Why health insurers won’t cover this $300,000-a-year rare disease drug
MarketWatch,
Alison Willis Hoke’s twin sons were among the 12 boys in a key clinical trial that helped get Sarepta Therapeutics Inc.’s…
Corticosteroid Treatments in Males With Duchenne Muscular Dystrophy
Overview of attention for article published in Journal of Child Neurology, November 2014
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (95th percentile)
-
High Attention Score compared to outputs of the same age and source (98th percentile)
Mentioned by
- news
- 2 news outlets
- policy
- 1 policy source
- 1 X user
- guideline
- 1 clinical guideline source
Readers on
- mendeley
- 22 Mendeley
